BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND CgA AND Treatment
7 results:

  • 1. Impact of FRAilty screening and Geriatric assessment and INtervention in older patients with epithelial ovarian cancer: A multicenter randomized clinical trial protocol (FRAGINOC).
    Daviu Cobián C; Oreskov JO; Blaakaer J; Jespersen E; Jørgensen TL; Ryg J; Herrstedt J; Høgdall C; Lund CM; Seibæk L; Vinther A; Ekmann-Gade AW; Schnack TH
    J Geriatr Oncol; 2024 Apr; 15(3):101713. PubMed ID: 38326125
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Chlorogenic acid regulates the proliferation and migration of high-grade serous ovarian cancer cells through modulating the miR199a5p/DDR1 axis.
    Li W; Ping Z; Xuemei G; Hongjuan M; Yi H; Xiaoli L; Zhongxiang Z
    Acta Biochim Pol; 2022 Dec; 69(4):855-864. PubMed ID: 36508480
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. GERiatric Screening in the treatment of elderly patients with ovarian Carcinoma (GERSOC): study protocol for a pragmatic, cluster randomised controlled trial.
    van Soolingen NJ; Smorenburg CH; Hamaker ME; Groen WG; Retèl VP; Lok CAR; van de Poll-Franse LV; Trum JW
    Trials; 2020 Feb; 21(1):214. PubMed ID: 32087750
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Chemotherapy for ovarian cancer in the older adult.
    Steer CB
    Curr Treat Options Oncol; 2009 Aug; 10(3-4):159-70. PubMed ID: 19370420
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.
    Moreno-Bueno G; Fernandez-Marcos PJ; Collado M; Tendero MJ; Rodriguez-Pinilla SM; Garcia-Cao I; Hardisson D; Diaz-Meco MT; Moscat J; Serrano M; Palacios J
    Cancer Res; 2007 Mar; 67(5):1927-34. PubMed ID: 17332319
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Management of cancer in the elderly.
    Balducci L
    Oncology (Williston Park); 2006 Feb; 20(2):135-43; discussion 144, 146, 151-2. PubMed ID: 16562648
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Elevated serum chromogranin A is detectable in patients with carcinomas at advanced disease stages.
    Wu JT; Erickson AJ; Tsao KC; Wu TL; Sun CF
    Ann Clin Lab Sci; 2000 Apr; 30(2):175-8. PubMed ID: 10807161
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.